This work mitigates a big issue with the first gene drive systems, which is the accumulation of drive-resistant mosquitoes that could still transmit malaria parasites,” said UCI vector biologist Anthony James. Steve Zylius / UCI
New CRISPR-based gene drive approach successfully overcomes issue of resistance in females
Employing a strategy known as “population modification,” which involves using a CRISPR-Cas9 gene drive system to introduce genes preventing parasite transmission into mosquito chromosomes, University of California researchers have made a major advance in the use of genetic technologies to control the transmission of malaria parasites.
University of California, Irvine postdoctoral researcher Adriana Adolfi, in collaboration with colleagues at UCI, UC Berkeley and UC San Diego, followed up on the group’s pioneering effort to develop CRISPR-based gene drive systems for making mosquito vectors resistant to transmitting malaria parasites by increasing gene drive effectiveness in female mosquito progeny.
“This work mitigates a big issue with the first gene drive systems, which is the accumulation of drive-resistant mosquitoes that could still transmit malaria parasites,” said UCI vector biologist Anthony James, the Donald Bren Professor of Microbiology & Molecular Genetics and Molecular Biology & Biochemistry, who was a co-primary investigator on the study.
“The second-generation gene drive system described in this paper can be applied to any of the several thousand genes that are essential for insects to survive or reproduce,” said UC San Diego Distinguished Professor Ethan Bier, a co-author of the study and science director at the Tata Institute for Genetics and Society. “While it was developed in fruit flies, this system is readily transportable to a broad selection of insect species that serve as vectors for devastating disorders such as Chagas disease, sleeping disease, leishmaniasis and arboviral diseases.”
Study results appear in Nature Communications. Link to study: https://www.nature.com/articles/s41467-020-19426-0
They describe a highly efficient second-generation version of the team’s original gene drive, developed for the Indo-Pakistani malaria vector mosquito Anopheles stephensi. The 2015 work, published in Proceedings of the National Academy of Sciences, was the first demonstration of a CRISPR-based gene drive in mosquitoes.
In that first study, the gene drive was transmitted to about 99 percent of progeny when the parent in which the gene drive was inserted was a male but only 60 to 70 percent of offspring when the parent in which the gene drive was inserted was a female. A significant number of drive-resistant chromosomes are generated in females; this, in principle, could allow those females to continue to transmit parasites.
Adolfi, lead author of the new study, and collaborators solved the failure to drive efficiently through females by equipping the gene drive with a functional copy of the target gene into which the drive is inserted. Normal function of this target gene is required in this mosquito species for female survival and fertility after she feeds on blood, and its functionality is usually disrupted when the drive system is inserted into the gene.
The resulting female mosquitoes showed strong and consistent drive in a population cage study and negligible production of drive-resistant chromosomes. This strategy of inserting a gene drive into a gene essential for viability or fertility and at the same time including a functional gene that rescues the loss of viability or fertility provides a general solution to drive resistance through females. Also, as with a catalytic converter removing combustion pollution from automobiles, the new system efficiently eliminates genetic errors made in the drive process.
This gene drive system – in combination with genes for blocking parasite transmission – can now be used to design field-ready strains of mosquitoes. Thorough testing is required to demonstrate safety and efficacy before advancing to field testing.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Blocking malaria transmission
- New monoclonal antibody vaccine slashes malaria risk in children
A recent study demonstrates that the monoclonal antibody-based vaccine L9LS is safe for children aged 6 to 10 and significantly reduces the risk of malaria infection and clinical symptoms by 70% and ...
- Vaccines are a glimmer of hope against malaria, but the battle has only just begun
By the time you reach the end of this article, three children will have died from malaria – a disease that casts a dark shadow over nearly half of the world’s population, claiming victims ...
- World Malaria Day: Revealing barriers and solutions
Today on World Malaria Day, we look at the continued effects of the disease. Recent efforts to combat malaria have come to a halt ...
- Can climate change accelerate transmission of malaria? New research sheds light on impacts of temperature
Malaria is a mosquito-borne disease caused by a parasite that spreads from bites of infected female Anopheles mosquitoes. If left untreated in humans, malaria can cause severe symptoms, health ...
- Can climate change accelerate transmission of malaria? Pioneering research sheds light on impacts of temperature
A groundbreaking study published in the journal Nature Communications, researchers at the University of Florida, Pennsylvania State University and Imperial College, combined novel experimental data ...
Go deeper with Google Headlines on:
Blocking malaria transmission
[google_news title=”” keyword=”blocking malaria transmission” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
CRISPR-based gene drive
- Dynamic DNA structures and the formation of memory
In addition, using advanced CRISPR-based gene editing technology ... and functionally involved in the expression of different memory states. The study, led by Dr Paul Marshall at the Australian ...
- Mutant’s partner in crime could be target for future cancer therapy
Defects in RNA processing can promote cancer -- but the mutated proteins responsible can be hard to target. Fred Hutch Cancer Center and Memorial Sloan Kettering Cancer Center scientists discovered a ...
- Generative AI arrives in the gene editing world of CRISPR
Much like ChatGPT generates poetry, a new AI system devises blueprints for microscopic mechanisms that can edit your DNA.
- Denmark’s SNIPR Biome secures $5.48M funding from CARB-X for clinical trial of CRISPR therapy in cancer patients
SNIPR Biome, a Copanhagen-based clinical-stage biotech company pioneering precision medicines using CRISPR technology for microbial gene therapy, has secured ...
- News - Mammoth Biosciences
US biotech Mammoth Biosciences, which is building the next generation of CRISPR products to cure and detect disease, has reinforced its C-suite with the arrival of two industry veterans - Phil ...
Go deeper with Google Headlines on:
CRISPR-based gene drive
[google_news title=”” keyword=”CRISPR-based gene drive” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]